SCHEMBL6550908

SCHEMBL6550908

O=C1CC(c2ccccc2)(c2ccc(Br)cc2)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.41
GOPC Q9HD26 1/20 0.41
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
MDM2 Q00987 2/20 0.39
HSP90AA1 P07900 1/20 0.38
KDM4E B2RXH2 1/20 0.36
UTS2R Q9UKP6 1/20 0.36
FPR2 P25090 1/20 0.35
GAA P10253 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PKM P14618 1/20 0.35
POLB P06746 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30074263 0.90 CFTR (0.48) CFTRGOPCHSP90AA1KDM4EGAA
SCHEMBL181563 0.90 CFTR (0.48) CFTRGOPCHSP90AA1KDM4EGAA
SCHEMBL6552460 0.84 ESR1 (0.51) CFTRGOPCMDM2HSP90AA1KDM4E
SCHEMBL6550929 0.80 MAPT (0.46) CFTRGOPCOPRM1MEN1KMT2A
SCHEMBL28606394 0.80 MDM2 (0.40) CFTRGOPCOPRM1MDM2MEN1
SCHEMBL28609498 0.80 PGR (0.38) CFTRGOPCMDM2MEN1KMT2A
Propionic Acid SCHEMBL4796324 0.78 PKM (0.41) CFTRGOPCOPRM1KDM4EGAA
SCHEMBL14462993 0.77 S100A4 (0.42) CFTRGOPCHSP90AA1MEN1KMT2A
SCHEMBL28610336 0.73 NPSR1 (0.57) CFTRGOPCOPRM1GAAMEN1
SCHEMBL28357232 0.72 MAPT (0.44) CFTRGOPCKDM4EGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1047411-B1 SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS AND ANALOGUES THEREOF USEFUL FOR THE TREATMENT OR PREVENTION OF DISEASES CHARACTERIZED BY ABNORMAL CELL PROLIFERATION HARVARD COLLEGE (US) 2004-02-11 EP disclosed